209 related articles for article (PubMed ID: 32943931)
1. Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Manag Res; 2020; 12():7973-7981. PubMed ID: 32943931
[TBL] [Abstract][Full Text] [Related]
2. [Gastric signet ring cell adenocarcinoma: A distinct entity].
Tabouret T; Dhooge M; Rouquette A; Brezault C; Beuvon F; Chaussade S; Coriat R
Presse Med; 2014 Apr; 43(4 Pt 1):353-7. PubMed ID: 24440764
[TBL] [Abstract][Full Text] [Related]
3. Update on diagnosis and treatment of early signet-ring cell gastric carcinoma: A literature review.
Tang YH; Ren LL; Mao T
World J Gastrointest Endosc; 2023 Apr; 15(4):240-247. PubMed ID: 37138936
[TBL] [Abstract][Full Text] [Related]
4. PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers.
Fourgeaud C; Derieux S; Mirshahi S; Besbes S; Chidiac J; Mahé I; Contant G; Pocard M; Soria J; Mirshahi M
Thromb Res; 2016 Apr; 140 Suppl 1():S184-5. PubMed ID: 27161709
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Signet Ring Cells in Gastric Cancer: The Higher Proportion, The Better Survival.
Li Y; Zhong Y; Xu Q; Zhu Z; Tian Y
Front Oncol; 2021; 11():713587. PubMed ID: 34858807
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of female reproductive factors on gastric signet-ring cell carcinoma.
Li Y; Zhong YX; Xu Q; Tian YT
World J Clin Cases; 2022 Jun; 10(16):5217-5229. PubMed ID: 35812665
[TBL] [Abstract][Full Text] [Related]
7. State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments.
Machlowska J; Pucułek M; Sitarz M; Terlecki P; Maciejewski R; Sitarz R
Cancer Manag Res; 2019; 11():2151-2161. PubMed ID: 30936747
[TBL] [Abstract][Full Text] [Related]
8. Tailored treatment for signet ring cell gastric cancer.
Mengardo V; Treppiedi E; Bencivenga M; Dal Cero M; Giacopuzzi S
Updates Surg; 2018 Jun; 70(2):167-171. PubMed ID: 29948660
[TBL] [Abstract][Full Text] [Related]
9. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
[TBL] [Abstract][Full Text] [Related]
10. Characterization of signet ring cell carcinoma of the stomach.
Otsuji E; Yamaguchi T; Sawai K; Takahashi T
J Surg Oncol; 1998 Apr; 67(4):216-20. PubMed ID: 9579367
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer.
Kao YC; Fang WL; Wang RF; Li AF; Yang MH; Wu CW; Shyr YM; Huang KH
Gastric Cancer; 2019 Mar; 22(2):255-263. PubMed ID: 30069742
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
[TBL] [Abstract][Full Text] [Related]
13. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
Ausch C; Rosen HR; Schiessel R
Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous carcinoma may have an inferior prognosis to signet ring cell carcinoma in patients with stages I and II gastric cancer.
Chu YX; Gong HY; Hu QY; Song QB
World J Gastrointest Oncol; 2020 Jan; 12(1):101-112. PubMed ID: 31966918
[TBL] [Abstract][Full Text] [Related]
15. Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival.
Solomon D; DeNicola N; Feingold D; Liu PH; Aycart S; Golas BJ; Sarpel U; Labow DM; Magge DR
J Surg Oncol; 2019 May; 119(6):758-765. PubMed ID: 30650185
[TBL] [Abstract][Full Text] [Related]
16. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the research of gastric signet ring cell carcinoma].
Xu Z; Jin Y; Fang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1196-1200. PubMed ID: 30370520
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological features and prognostic analysis of patients with signet ring cell gastric carcinoma].
Cui J; Liang H; Deng J; Ding X; Wang X; Zhang L; Liang Y; Jiang N
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):367-70. PubMed ID: 26463028
[TBL] [Abstract][Full Text] [Related]
19. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer.
Li FQ; Xu B; Wu YJ; Yang ZL; Qian JJ
Genet Mol Res; 2015 Jan; 14(1):739-47. PubMed ID: 25730011
[TBL] [Abstract][Full Text] [Related]
20. Signet-ring cell carcinoma in gastric biopsies: expecting the unexpected.
Golembeski CP; Genta RM
J Clin Pathol; 2013 Feb; 66(2):136-9. PubMed ID: 23212932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
